[ CAS No. 167484-18-6 ]

Name: 167484-18-6|Benzyl spiro[indoline-3,4'-piperidine]-1'-carboxylate|97%
Brand: Ambeed
SKU: A782114
Price: 26.0 USD
Availability: InStock
Rating: 98 (27 reviews)

{[proInfo.proName]} ,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

DV 2D 3D

3d Animation Molecule Structure of 167484-18-6

Structure of 167484-18-6 * Storage: {[proInfo.prStorage]}

Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 88K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 167484-18-6 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 167484-18-6 ]

SDS

Alternatived Products of [ 167484-18-6 ]

Product Details of [ 167484-18-6 ]

CAS No. :	167484-18-6	MDL No. :	MFCD11007805
Formula :	C₂₀H₂₂N₂O₂	Boiling Point :	505.157°C at 760 mmHg
Linear Structure Formula :	-	InChI Key :	N/A
M.W :	322.40 g/mol	Pubchem ID :	10914256
Synonyms :

Calculated chemistry of of [ 167484-18-6 ]

Physicochemical Properties

Num. heavy atoms :	24
Num. arom. heavy atoms :	12
Fraction Csp3 :	0.35
Num. rotatable bonds :	4
Num. H-bond acceptors :	2.0
Num. H-bond donors :	1.0
Molar Refractivity :	101.12
TPSA :	41.57 Å²

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	Yes
CYP1A2 inhibitor :	No
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	Yes
CYP2D6 inhibitor :	Yes
CYP3A4 inhibitor :	Yes
Log Kp (skin permeation) :	-5.7 cm/s

Lipophilicity

Log Po/w (iLOGP) :	3.15
Log Po/w (XLOGP3) :	3.62
Log Po/w (WLOGP) :	2.68
Log Po/w (MLOGP) :	3.14
Log Po/w (SILICOS-IT) :	3.14
Consensus Log Po/w :	3.15

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	0.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-4.23
Solubility :	0.0192 mg/ml ; 0.0000595 mol/l
Class :	Moderately soluble
Log S (Ali) :	-4.18
Solubility :	0.0213 mg/ml ; 0.000066 mol/l
Class :	Moderately soluble
Log S (SILICOS-IT) :	-6.02
Solubility :	0.000306 mg/ml ; 0.000000951 mol/l
Class :	Poorly soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	3.5

Safety of [ 167484-18-6 ]

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P280-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H317	Packing Group:	N/A
GHS Pictogram:

Application In Synthesis of [ 167484-18-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Downstream synthetic route of [ 167484-18-6 ]

[ 167484-18-6 ] Synthesis Path-Downstream 1~31

1
[ 124-63-0 ]
[ 167484-18-6 ]
[ 184289-84-7 ]

Yield	Reaction Conditions	Operation in experiment
81%	With N-ethyl-N,N-diisopropylamine; In tetrahydrofuran; at 0 - 20℃;	Compound A (3.03 g, 9.4 mmol) was dissolved in tetrahydrofuran (30 mL) and cooled to 0C. diisopropylethylamine (1.8 mL, 10.3 mmol) and methanesulfonyl chloride (0. 8 mL, 10.3 mmol) were added slowly. The reaction was stirred over night at room temperature. The solvent was removed under vacuum and the crude material was dissolved in dichloromethane, washed successively with aqueous HC1 (1N), saturated aqueous NaHC03 and brine. The organic layer was dried over Na2S04. The dichloromethane was removed by evaporation and the crude material was crystallised from hot ethanol and a drop of acetic acid to give 3.06g (81 %) of B as a beige solid.
81%	With N-ethyl-N,N-diisopropylamine; In tetrahydrofuran; at 20℃;	Synthesis of B:; Compound A (3.03 g, 9.4 mmol) was dissolved in tetrahydrofuran (30 mL) and cooled to 0C. diisopropylethylamine (1.8 mL, 10.3 mmol) and methanesulfonyl chloride (0.8 mL, 10.3 mmol) were added slowly. The reaction was stirred over night at room temperature. The solvent was removed under vacuum and the crude material was dissolved in dichloromethane, washed successively with aqueous HCI (IN), saturated aqueous NaHC03 and brine. The organic layer was dried over Na2S04. The dichloromethane was removed by evaporation and the crude material was crystallised from hot ethanol and a drop of acetic acid to give 3.06g (81 %) of B as a beige solid.
68%	With triethylamine; In dichloromethane; at 0 - 25℃; for 3h;	Methanesulfonyl chloride (0.145 mL, 1.861 mmol) was added to a solution of benzyl spiro[indoline-3,4?-piperidine]-l?-carboxylate (Compound of step 1 of Example 116, 0.5 g, 0. 1.55 1 mmol) and triethylamine (0.648 mL, 4.65 mmol) in DCM (20 mL) at 0-5 C. The reaction mixture was stirred at RT for 3h. After completion of reaction, water (20 mL) and DCM (20 mL) was added to the reaction mixture. The organic layer was separated and dried over Na2504. The solvent was evaporated and the residue was purified by flash column chromatography (silica gel column, 1-70% EtOAc/petroleum ether as eluent) to obtain the title compound (0.42 g). Yield: 68%; 1H NMR (DMSO-d6, 300 MHz): 5 1.60 (s, 3H), 1.70- 1.74 (m, 2H), 2.93 (s, 3H), 2.97-3.02 (m, 1H), 3.87 (s, 2H), 4.25 (br s, 2H), 5.19 (s, 2H), 7.09 (t, J = 7.2 Hz, 1H), 7.15 (d, J = 7.2 Hz, 1H), 7.25 (d, J = 7.2 Hz, 1H), 7.40 (brs, 6H); MS (mlz): [M] 400.1.

Reference： [1]Patent: WO2005/46682,2005,A1 .Location in patent: Page/Page column 90
[2]Patent: WO2005/97788,2005,A2 .Location in patent: Page/Page column 86
[3]Patent: WO2015/28960,2015,A1 .Location in patent: Page/Page column 151
[4]Tetrahedron,1997,vol. 53,p. 10983 - 10992
[5]Chinese Chemical Letters,2012,vol. 23,p. 661 - 664

2
[ 184289-85-8 ]
[ 167484-18-6 ]

Reference： [1]Tetrahedron,1997,vol. 53,p. 10983 - 10992
[2]Chinese Chemical Letters,2012,vol. 23,p. 661 - 664

3
[ 13139-17-8 ]
[ 171-75-5 ]
[ 167484-18-6 ]

Yield	Reaction Conditions	Operation in experiment
69%	In tetrahydrofuran; at 20℃; for 1h;	To a stirred solution of 49a (0.90 g, 4.78 mmol) in dry THF (25 mL) was added (N-benzyloxycarbonyloxy)-succinimide (1.2 g, 4.8 mmol) in THF (5 mL) over a 2-min period of time at rt under N2. The resulting mixture was stirred at rt for 1 h. EtOAc was added. It was washed with sat'd NaHCO3, H2O, brine, dried over MgSO4, filtered, and concentrated to dryness. The residue was purified by flash chromatography (silica gel, hexanes/EtOAc) to give pure 49b as colorless crystals (0.96 g, yield: 69%). LC-MS ESI 323.15 (M+H)+(tR=2.62 min, 10%-90% MeOH in H2O in a 4-min run).
69%	In tetrahydrofuran; at 20℃; for 1.03333h;	6b. Spiro[3H-indole-3,4'-piperidine]-1'-carboxylic acid, 1,2-dihydro-, Phenylmethyl Ester:; To a stirred solution of 6a (0.90 g, 4.78 mmol) in dry THF (25 mL) was added (N-benzyloxycarbonyloxy)-succinimide (1.2 g, 4.8 mmol) in THF (5 mL) over a 2-min period of time at rt under N2. The resulting mixture was stirred at rt for 1 h. EtOAc was added. It was washed with saturated NaHCO3, H2O, brine, dried over MgSO4, filtered, and concentrated to dryness. The residue was purified by flash chromatography (silica gel, hexanes/EtOAc) to give pure 6b as colorless crystals (0.96 g, yield: 69%). LC-MS ESI 323.15 (M+H)+(tR=2.62 min, 10%-90% MeOH in H2O in a 4-min run).

Reference： [1]Tetrahedron,2004,vol. 60,p. 4875 - 4878
[2]Patent: US2005/261244,2005,A1 .Location in patent: Page/Page column 54
[3]Patent: US2006/293281,2006,A1 .Location in patent: Page/Page column 73
[4]Journal of Medicinal Chemistry,2013,vol. 56,p. 9275 - 9295

4
[ 252002-43-0 ]
[ 167484-18-6 ]

Reference： [1]Tetrahedron,2004,vol. 60,p. 4875 - 4878

5
[ 726198-18-1 ]
[ 167484-18-6 ]

Reference： [1]Tetrahedron,2004,vol. 60,p. 4875 - 4878

6
[ 498-94-2 ]
[ 167484-18-6 ]

Reference： [1]Tetrahedron,1997,vol. 53,p. 10983 - 10992
[2]Chinese Chemical Letters,2012,vol. 23,p. 661 - 664

7
[ 10314-98-4 ]
[ 167484-18-6 ]

Reference： [1]Tetrahedron,1997,vol. 53,p. 10983 - 10992

8
[ 138163-08-3 ]
[ 167484-18-6 ]

Reference： [1]Tetrahedron,1997,vol. 53,p. 10983 - 10992
[2]Chinese Chemical Letters,2012,vol. 23,p. 661 - 664

9
[ 501-53-1 ]
(+-)-2.3-diamino-propionic acid [ No CAS ]
[ 167484-18-6 ]

Reference： [1]Tetrahedron,1997,vol. 53,p. 10983 - 10992

10
[ 10314-99-5 ]
[ 167484-18-6 ]

Reference： [1]Tetrahedron,1997,vol. 53,p. 10983 - 10992

11
[ 100-63-0 ]
1.4-diphenyl-butanedione-(2.3) [ No CAS ]
[ 167484-18-6 ]

Reference： [1]Tetrahedron,1997,vol. 53,p. 10983 - 10992

12
[ 167484-18-6 ]
[ 159634-47-6 ]

Reference： [1]Tetrahedron,1997,vol. 53,p. 10983 - 10992

13
[ 167484-18-6 ]
[ 178261-41-1 ]

Reference： [1]Tetrahedron,1997,vol. 53,p. 10983 - 10992
[2]Chinese Chemical Letters,2012,vol. 23,p. 661 - 664
[3]Patent: WO2015/28960,2015,A1

14
[ 167484-18-6 ]
[ 180465-67-2 ]

Reference： [1]Tetrahedron,1997,vol. 53,p. 10983 - 10992
[2]Chinese Chemical Letters,2012,vol. 23,p. 661 - 664

15
[ 167484-18-6 ]
[ 180465-66-1 ]

Reference： [1]Tetrahedron,1997,vol. 53,p. 10983 - 10992
[2]Chinese Chemical Letters,2012,vol. 23,p. 661 - 664

16
[ 167484-18-6 ]
[ 159634-87-4 ]

Reference： [1]Tetrahedron,1997,vol. 53,p. 10983 - 10992
[2]Chinese Chemical Letters,2012,vol. 23,p. 661 - 664

17
[ 167484-18-6 ]
MK-677 [ No CAS ]

Reference： [1]Tetrahedron,1997,vol. 53,p. 10983 - 10992
[2]Chinese Chemical Letters,2012,vol. 23,p. 661 - 664

18
[ 138163-08-3 ]
[ 100-63-0 ]
[ 167484-18-6 ]

Yield	Reaction Conditions	Operation in experiment
84%		Preparation 1; Benzyl spiro[in line-3,4'-piperidine]- 1 '-carboxylateA solution of phenyl hydrazine (1.29 g, 12.0 mmol) and trifluoroacetic acid (3.0 mL) in a 49/1 solution of toluene/acetonitrile (50 mL) is heated at 35 C. 4-Formyl- piperidine- l -carboxylic acid benzyl ester (2.7 g, 10.91 mmol) is dissolved in a 49/1 solution of toluene/acetonitrile (10 mL) and added dropwise to the mixture(WO2005046682). The mixture is stirred at 35 C overnight. The resulting solution is cooled to 0 C, and methanol (5 mL) is added. NaBFLt (0.619 g, 16.38 mmol) is added slowly to the solution and the mixture is stirred for 45 min. The mixture is washed with aqueous NH4OH (6%, 25 mL) and brine (30 mL), dried over sodium sulfate, and evaporated to dryness to give a yellow solid. The crude solid is recrystallised from EtOAc to give a pale yellow solid (1.25 g, 1st crop). The mother liquor is evaporated and purified by flash chromatography, eluting with hexane:ethyl acetate (8:2) to give the title compound as a pale yellow solid (1.2 g, 2n crop) with a total yield (2.4 g, 84%). ESI/MS m/z 323 (M+H)+.
76%		Preparation 1Benzyl spiro[indoline-3,4'-piperidine]-1'-carboxylate A solution of phenyl hydrazine (1.29 g, 12.0 mmol) and trifluoroacetic acid (3.0 mL) in a 49:1 solution of toluene:acetonitrile (50 mL) is heated at 35 C. 4-Formyl-piperidine-1-carboxylic acid benzyl ester (2.7 g, 10.91 mmol) is dissolved in a 49:1 solution of toluene:acetonitrile (10 mL) and added dropwise to the mixture (WO2005046682). The mixture is stirred at 35 C. overnight. The resulting solution is cooled to 0 C., and methanol (5 mL) is added. NaBH4 (0.619 g, 16.38 mmol) is added portion wise to the solution and the mixture is stirred for 45 min. The reaction mixture is washed with aqueous NH4OH (6%, 25 mL) and brine (30 mL), dried over sodium sulfate, and evaporated to dryness to give a yellow solid. The crude solid is recrystallised from EtOAc to give a yellow solid (1.25 g, 1st crop). The mother liquor is evaporated and purified by silica gel chromatography, eluting with hexane:ethyl acetate (8:2) to give the title compound as a pale yellow solid (1.2 g, 2nd crop) with a total yield of (2.4 g, 76%). ESI/MS m/z 323 (M+H)+.
75%		A solution of phenylhydrazine (2.38 g, 22 mmol) and trifluoroacetic acid (5 mL) in Toluene/acetonitrile (49/1) (100 mL) was heated at 35C. N-benzyloxycarbonyl 4- formylpiperidine (4.94 g, 20 mmol) was dissolved in 20 mL of toluene/acetonitrile (49/1) and added dropwise to the mixture, which was stirred at 35C overnight. The resulting solution was then cooled to 0C, and methanol (10 mL) was added. NaBH4 (1.13 g, 30 mmol) was added very slowly to the solution which was stirred for a further 45 min. The reaction mixture was washed with aqueous NH40H 6% (40 mL). Methanol (2 mL) was added and the organic layer was washed with brine (40 mL) then dried over Na2S04 and evaporated. The crude material was purified by column chromatography on silica gel, eluting with ethyl acetate/cyclohexane (1/1) to give 4.85 g (75%) of A as a pale yellow solid.

75%		Synthesis of advanced intermediate E Synthesis of A:; A solution of phenylhydrazine (2.38 g, 22 mmol) and trifluoroacetic acid (5 mL) in Toluene/acetonitrile (49/1) (100 mL) was heated at 35C. N-benzyloxycarbonyl 4- formylpiperidine (4.94 g, 20 mmol) was dissolved in 20 mL of toluene/acetonitrile (49/1) and added dropwise to the mixture, which was stirred at 35C overnight. The resulting solution was then cooled to 0C, and methanol (10 mL) was added. NaBH4 (1.13 g, 30 mmol) was added very slowly to the solution which was stirred for a further 45 min. The reaction mixture was washed with aqueous NH40H 6% (40 mL). Methanol (2 mL) was added and the organic layer was washed with brine (40 mL) then dried over Na2S04 and evaporated. The crude material was purified by column chromatography on silica gel, eluting with ethyl acetate/cyclohexane (1/1) to give 4.85 g (75%) of A as a pale yellow solid.
74%		A solution of phenyl hydrazine (5.96 mmol) and trifluoroacetic acid (1.5 mL) in a solvent system of toluene: acetonitrile (49:1) (25 mL) was stirred at 35 C. To this reaction mixture, a solution of benzyl 4-formylpiperidine- 1 -carboxylate (5.46 mmol) in a solvent system of toluene: acetonitrile (49:1) (5 mL) was added drop wise. The reaction mixture was stirred overnight at 35 C. The reaction mixture was then cooled in ice bath and MeOH (2.5 mL) was added, followed by the addition of sodium borohydride (8.16 mmol) in portions. The reaction mixture was then stirred for 45 minutes. After the completion of reaction, the reaction mixture was diluted with ethyl acetate (25 mL), washed with 5% aqueous ammonia, brine, dried over Na2504 and concentrated. The residue was purified by flash column chromatography (silica gel column, 10%-20% ethyl acetate/ petroleum ether). Yield: 74%; 1H NMR (CDC13, 300 MHz): 7.391 (m, 5H), 7.100 (m, 2H), 6.789 (t, J= 7.5, 1H), 6.686 (d, J = 7.5, 1H), 5.182 (s, 2H), 4.153 (bs, 2H), 3.501 (s, 2H), 3.067 (t, J = 14.1, 2H), 1.895 (m, 4H); MS (mlz): 323.1 (M+H) and 345.1 (M+Na).
49%		To a solution of phenylmethyl 4-formyl-1-piperidinecarboxylate (81 mmol) in 200 mL of DCM cooled in an ice bath was added phenylhydrazine (81 mmol). After stirring for approximately 15 min, TFA (202.5 mmol) was added over a period of 5 min. The mixture was allowed to slowly warm to room temperature and stir overnight. The mixture was then cooled in and ice bath and NaBH4 (121.5 mmol) was added in small portions over 15 min. The resulting solution was allowed to warm to room temperature and stir for one hour, whereupon a 10% solution of NH4OH (~100 mL) was added. After stirring for 30 min, the mixture was separated, and the aqueous layer extracted with DCM. The combine organic solutions were dried over Na2SO4 and concentrated. The residue was purified by column chromatography eluding with 0-10% MeOH in DCM. 12.72 g (39.4 mmol, 49% yield) of the desired product phenylmethyl 1,2-dihydro-1'H-spiro[indole-3,4'-piperidine]-1'-carboxylate was obtained. MS (ES) m/e 323 [M+H]+.
487 mg		(Reference Example 33) 1'-benzyloxycarbonyl-1-tert-butyloxycarbonylspiro[indoline-3,4'-piperidine] <Step 1> First, 1-benzyloxycarbonyl-4-formylpiperidine (514.5 mg) was dissolved in chloroform (10 mL), phenylhydrazine (0.245 mL) and trifluoroacetic acid (0.478 mL) were added thereto, and the mixture was stirred at 35C for 14 hours. After that, sodium triacetoxyborohydride (881.9 mg) was added thereto, and the mixture was further stirred at room temperature for 1 hour. A saturated sodium hydrogen carbonate aqueous solution was added to the reaction solution, followed by extraction with chloroform. The organic layer was dried with anhydrous magnesium sulfate and was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (ethyl acetate/n-hexane = 50/50) to obtain 1'-benzyloxycarbonylspiro[indoline-3,4'-piperidine] (487.0 mg). MS (ESI)m/z:323[M+H]+.

Reference： [1]Patent: WO2011/66183,2011,A1 .Location in patent: Page/Page column 11
[2]Patent: US2011/92531,2011,A1 .Location in patent: Page/Page column 8
[3]Patent: WO2005/46682,2005,A1 .Location in patent: Page/Page column 89; 90
[4]Patent: WO2005/97788,2005,A2 .Location in patent: Page/Page column 85
[5]Patent: WO2015/28960,2015,A1 .Location in patent: Page/Page column 86; 149; 150
[6]Tetrahedron,2010,vol. 66,p. 573 - 577
[7]Patent: US2008/318990,2008,A1 .Location in patent: Page/Page column 22
[8]Bioorganic and Medicinal Chemistry Letters,2008,vol. 18,p. 3359 - 3363
[9]Patent: EP3480198,2019,A1 .Location in patent: Paragraph 0237; 0238

19
[ 1493-27-2 ]
[ 167484-18-6 ]
[ 870072-74-5 ]

Yield	Reaction Conditions	Operation in experiment
91%	at 175℃; for 8h;	6c. Spiro[3H-indole-3,4'-piperidine]-1'-carboxylic acid, 1,2-dihydro-1-(2-nitrophenyl)-, Phenylmethyl Ester:; To 6b (200 mg, 0.62 mmol, 10025-B) was added 2-fluoro-nitrobenzene (400 mg, 2.8 mmol). The reaction was stirred at 175 C. for 8 h. The desired compound was purified by column chromatography using 0% to 40% EtOAc in hexanex as eluting gradient to afford 6c (250 mg, 91%). MS (ES) m/z 444 [M+H]+.
70%	at 200 - 220℃; for 0.5h;microwave;	49b (0.25 g) and ortho-fluoronitrobenzene (0.40 mL) was heated with stirring at 200-220 C. for 30 min under microwave irradiation. The resulting mixture was purified via flash chromatography (silica gel, hexanes:EtOAc=1:0 to 1:1) to give 49c (0.24 g, yield: 70%). LC-MS (ESI) 444.

Reference： [1]Patent: US2006/293281,2006,A1 .Location in patent: Page/Page column 74
[2]Patent: US2005/261244,2005,A1 .Location in patent: Page/Page column 55
[3]Journal of Medicinal Chemistry,2013,vol. 56,p. 9275 - 9295

20
[ 121-44-8 ]
[ 75-36-5 ]
[ 167484-18-6 ]
[ 167484-19-7 ]

Yield	Reaction Conditions	Operation in experiment
2.93 g (77%)	With acetic acid;palladium-carbon; In ethanol; dichloromethane;	1-Acetyl-spiro(indoline-3,4'-piperidine) Acetyl chloride (1.4 mL, 19.9 mmol) was added to a solution of 5.35 g (16.6 mmol) of <strong>[167484-18-6]1'-benzyloxycarbonyl-spiro(indoline-3,4'-piperidine)</strong> in 33 mL of CH2 Cl2 and 3.2 mL (23.2 mmol) of Et3 N keeping the temperature between 0-5 C. by cooling in ice bath. After 10 min the cold bath was removed and reaction was stirred for 30 min at which time a TLC indicated complete reaction. The solution was diluted with CH2 Cl2 and washed with water, brine and dried over Na2 SO4. The filtrate was concentrated to a thick oil and the oil was dissolved in 40 mL of EtOH. Acetic acid (3 mL) and 0.8 g of 10% Pd/C were added to the solution and the resulting mixture was hydrogenated on a Parr apparatus for 3 h. The catalyst was filtered and washed with EtOAc and the combined filtrate was concentrated. The residue was partitioned between CH2 Cl2 and water and 2N NaOH was added to this mixture until the aqueous layer was basic. The layers were separated and the aqueous layer was extracted with CH2 Cl2. The combined organic layer was washed with brine, dried over Na2 SO4 and the filtrate was concentrated to give 2.93 g (77%) of the title compound sufficiently pure for use in the next reaction.
2.93 g (77%)	With acetic acid;palladium-carbon; In ethanol; dichloromethane;	1-Acetyl-spiro(indoline-3,4'-piperidine) Acetyl chloride (1.4 mL, 19.9 mmol) was added to a solution of 5.35 g (16.6 mmol) of <strong>[167484-18-6]1'-benzyloxycarbonyl-spiro(indoline-3,4'-piperidine)</strong> in 33 mL of CH2 Cl2 and 3.2 mL (23.2 mmol) of Et3 N keeping the temperature between 0-5 C. by cooling in ice bath. After 10 min the cold bath was removed and reaction was stirred for 30 min at which time a TLC indicated complete reaction. The solution was diluted with CH2 Cl2 and washed with water, brine and dried over Na2 SO4. The filtrate was concentrated to a thick oil and the oil was dissolved in 40 mL of EtOH. Acetic acid (3 mL) and 0.8 g of 10% Pd/C were added to the solution and the resulting mixture was hydrogenated on a Parr apparatus for 3 h. The catalyst was filtered and washed with EtOAc and the combined filtrate was concentrated. The residue was partitioned between CH2 Cl2 and water and 2N NaOH was added to this mixture until the aqueous layer was basic. The layers were separated and the aqueous layer was extracted with CH2 Cl2. The combined organic layer was washed with brine, dried over Na2 SO4 and the filtrate was concentrated to give 2.93 g (77%) of the title compound sufficiently pure for use in the next reaction.

Reference： [1]Patent: US5962462,1999,A
[2]Patent: US6013652,2000,A

22
[ 24391-41-1 ]
[ 167484-18-6 ]
benzyl 1-(5-cyano-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,2-dihydro-1'H-spiro[indole-3,4'-piperidine]-1'-carboxylate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
74%	With potassium dihydrogenphosphate; phosphoric acid; In dimethyl sulfoxide; at 80℃; for 12h;	A solution of <strong>[24391-41-1]4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile</strong> (1.0 g, 5.6 mmol), benzyl 1 ,2-dihydro-1'H-spiro[indole-3,4'-piperidine]-1'-carboxylate (1.80 g, 5.6 mmol), phosphoric acid (0.11g, 1.1 mmol), and potassium dihydrogen phosphate (0.76 g, 5.6 mmol) in 3 mL of dimethyl sulfoxide has heated at 8O0C for 12 h. The mixture was poured into 25% sodium bicarbonate in water (by weight) and extracted 3x with ethyl acetate. The combined organics were dried over sodium sulfate. Chromatography on silica gel, eluting with 62-65% ethyl acetate / hexanes afforded 1.94 g (74%) of benzyl 1-(5-cyano-7H-pyrrolo[2,3-d]pyrimidin- 4-yl)-1 ,2-dihydrc-1Eta-spiro[indole-3,4'-piperidine]-r-carboxylate; TR 7.54 min (HPLC Conditions H).

Reference： [1]Patent: WO2006/90261,2006,A1 .Location in patent: Page/Page column 63
[2]Bioorganic and Medicinal Chemistry Letters,2008,vol. 18,p. 3359 - 3363

23
[ 1618-36-6 ]
[ 167484-18-6 ]
benzyl 1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,2-dihydro-1'H-spiro[indole-3,4'-piperidine]-1'-carboxylate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
51%	In ethyl acetate; at 100℃; for 48h;	A suspension of 4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine (0.05 g, 0.30 mmol) and benzyl 1 ,2-dihydro-1'H-spiro[indole-3,4'-piperidine]-1'-carboxylate (0.0961 g, 0.3 mmol) in ethyl acetate was heated to 1000C, boiling off the ethyl acetate. The mixture was heated at 1000C for 48 h. The cooled reaction was taken up in ethyl acetate and saturated sodium bicarbonate. The layers were separated and the aqueous layer was extracted three times with ethyl acetate, and the combined organics were washed with brine, dried over sodium sulfate and evaporated. The crude material was absorbed on silica gel and chromatographed with 1:1 ethyl acetate/ hexanes to afford 0.693 g (51%) of benzyl 1-(5-methyl-7H-pyrrolo[2,3- dlpyrimidin^-yO-i ^-dihydro-i'H-spirotindole-S^'-piperidinel-i'-carboxylate; TR 7.80 min (HPLC conditions H).

Reference： [1]Patent: WO2006/90261,2006,A1 .Location in patent: Page/Page column 61
[2]Bioorganic and Medicinal Chemistry Letters,2008,vol. 18,p. 3359 - 3363

24
[ 167484-18-6 ]
[ 55052-28-3 ]
[ 908287-33-2 ]

Yield	Reaction Conditions	Operation in experiment
52%	With trifluoroacetic acid; In N,N-dimethyl-formamide; at 65℃; for 48h;	Benzyl 1 ,2-dihydro-1Eta-spiro[indole-3,4'-piperidine]-1'-carboxylate (2 g, 6.2 mmol) is mixed with 4-chloro-1H-pyrrolo[2,3-b]pyridine (prepared as described in WO 2003000690), DMF (1 mL) and TFA (0.478 mL). The suspension is heated to 650C for 2 days. The reaction is then cooled to room temperature and partitioned between EtOAc and a solution of saturated sodium bicarbonate in water. The EtOAc layer is removed and the water layer is extracted twice more. The combined organics are dried over sodium sulfate, filtered, and the solvent is removed in vacuo. The resulting solid is then purified by column chromatography (99% EtOAc + 1 % Et3N) to provide 1.41g (52% yield) of benzyl 1-(1 H-pyrrolo[2,3-b]pyridin-4-yl)- 1 ,2-dihydro-1Eta-spiro[indole-3,4'-piperidine]-1'-carboxylate as an orange solid. 1H NMR (500 EPO <DP n="75"/>MHz, DMSOd6) delta 11.56 (1H, br. s), 8.05 (1H1 d, J = 6.0 Hz), 7.38-7.40 (4H, m), 7.31-7.35 (2H, m), 7.27 (1 H, br. d, J = 7.0 Hz), 7.12 (1H1 td, J = 8.0, 1.0 Hz), 7.05 (1H, d, J = 8.0 Hz), 6.92 (1H1 d, J = 6.0 Hz), 6.85 (1H, t, J = 7.8 Hz)1 6.43-6.44 (1H, m), 5.11 (2H, br. s), 4.18 (2H, s), 3.98- 4.06 (2H, m), 2.98-3.19 (2H, m), 1.81 (2H, dt, J = 12.9, 4.7 Hz), 1.67-1.75 (2H, m); LRMS (M+): 439.2; HPLC retention time: 1.99 min. (HPLC method I).

Reference： [1]Patent: WO2006/90261,2006,A1 .Location in patent: Page/Page column 73-74

25
[ 3680-69-1 ]
[ 167484-18-6 ]
[ 908283-37-4 ]

Yield	Reaction Conditions	Operation in experiment
	With N-ethyl-N,N-diisopropylamine; In dimethyl sulfoxide; at 100℃; for 25.67h;	4-Chloro-7H-pyrrolo[2,3-d]pyrimidine (0.4 M, 300 ul, 120 umol) and benzyl 1,2-dihydro- I'H-spirotindole-S^'-piperidinel-r-carboxylate (0.4 M, 300 ul, 120 umol) in DMSO were mixed together. DIEA (neat, 75 ul, 431 umol) was added. The contents were concentrated to dryness in a Genevac and the reaction vial was capped and heated at 1000C for 25 h, 40 min to form benzyl 1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1 ,2-dihydro-1Eta-spiro[indole-3,4'-piperidine]-1'- carboxylate. THF (0.5 ml) was added to the mixture, followed by lithium aluminum hydride (1 M in THF, 0.24 ml, 240 umol). The resulting solution was shaken at room temperature for 2 h, 20 min. Water (2 ml) and dichloroethane (2 ml) were added to the reaction mixture and the layers EPO <DP n="71"/>were separated. The aqueous layer was re-extracted with dichloroethane (2 ml). The combined organic layers were concentrated to dryness to afford 27.5 mg of a crude product. The material was dissolved in DMSO (1 ml) and purified by HPLC to afford 9.4 mg of the title compound as a TFA salt (18% overall yield after two steps). APCI LCMS: Observed mass: 320.13 (M+1). Retention time: 1.9 min (Method E).

Reference： [1]Patent: WO2006/90261,2006,A1 .Location in patent: Page/Page column 69
[2]Bioorganic and Medicinal Chemistry Letters,2008,vol. 18,p. 3359 - 3363

26
[ 871335-85-2 ]
[ 167484-18-6 ]
benzyl 1-(3-methyl-1H-pyrazolo[2,3-d]pyrimidin-4-yl)-1,2-dihydro-1'H-spiro[indole-3,4'-piperidine]-1'-carboxylate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
53%	In ethyl acetate; at 100℃; for 4h;	A mixture of 4-chloro-3-methyl-1 H-pyrazolo[3,4-d]pyrimidine (1.30 g, 7.7 mmol) and benzyl 1 ,2-dihydro-1'H-spiro[indole-3,4'-piperidine]-1'-carboxylate (2.48 g, 7.7 mmol) in ethyl acetate was heated to 100 0C, boiling off the ethyl acetate. The mixture was heated at 1000C for 4 h and then cooled to rt. The mixture was taken up in 4:1 dichloromethane/ methanol and 2M ammonia in methanol was added until neutral. The mixture was evaporated to dryness and chromatographed on silica gel, eluting with 60-90 % ethyl acetate/ hexanes to afford 1.86 g (53%) of benzyl 1-(3-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-1 ,2-dihydro-1'H-spiro[indole-3,4'- piperidine]-1'-carboxylate; TR 7.35 min (HPLC conditions H).

Reference： [1]Patent: WO2006/90261,2006,A1 .Location in patent: Page/Page column 79

27
5-benzyl-4-chloro-7H-pyrrolo[2,3-d]pyrimidine [ No CAS ]
[ 167484-18-6 ]
benzyl 1-(5-benzyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,2-dihydro-1'H-spiro[indole-3,4'-piperidine]-1'-carboxylate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
50%	In ethyl acetate; at 100℃; for 24h;	A suspension of 5-benzyl-4-chloro-7H-pyrrolo[2,3-d]pyrimidine (0.0683 g, 0.28 mmol) and benzyl i^-dihydro-i'H-spirotindole-S^'-piperidineJ-i'-carboxylate (0.0904 g, 0.28 mmol) in ethyl acetate was heated to 10O0C, boiling off the ethyl acetate. The mixture was heated at 1000C for 24 h. The mixture was taken up in 4:1 dichloromethane/ methanol and 2M ammonia in methanol was added until neutral. The mixture was evaporated to dryness and chromatographed on silica gel, eluting with 2-2.3 % methanol/ methylene chloride to afford 0.075 g (50%) of benzyl 1-(5-benzyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1 ,2-dihydro-1'H- spiro[indole-3,4'-piperidine]-1'-carboxylate; TR 8.62 min (HPLC conditions H).

Reference： [1]Patent: WO2006/90261,2006,A1 .Location in patent: Page/Page column 65
[2]Bioorganic and Medicinal Chemistry Letters,2008,vol. 18,p. 3359 - 3363

28
[ 541-41-3 ]
[ 167484-18-6 ]
[ 937255-10-2 ]

Yield	Reaction Conditions	Operation in experiment
31%	With triethylamine; In dichloromethane; at 20℃; for 18h;	Preparation 1251 '-benzyl 1-ethyl 1'H-spiro?ndole-3.4'-piperidinel-1 ,1'(2H)-dicarboxylateBenzyl 1 ,2-dihydro-1eta-spiro[indole-3,4'-piperidine]-r-carboxylate [described in J. Xie et al., Tetrahedron, 2004, 60, 4875-4878] (251 mg, 0.78 mmol), ethyl chloroformate (93 mg, 0.86 mmol) and triethylamine (0.15 ml, 0.97 mmol) were stirred in dichloromethane (5 ml) at room temperature for 18 hours. The organic phase was washed with saturated aqueous sodium hydrogen carbonate (5 ml), dried (MgSO4), and loaded onto a silica gel column. Gradient elution with cydohexane:Et2O (90:10 - 50:50) yielded the title compound as a colourless gum (95 mg, 0.24 mmol, 31 %). MS m/z (APCI) 395 [MH]+

Reference： [1]Patent: WO2007/57775,2007,A1 .Location in patent: Page/Page column 183

29
[ 79-22-1 ]
[ 167484-18-6 ]
[ 937255-09-9 ]

Yield	Reaction Conditions	Operation in experiment
29%	With triethylamine; In dichloromethane; at 20℃; for 18h;	Preparation 1241'-benzyl 1-methyl 1'H-spiro?ndole-3,4'-piperidine1-1 ,1'(2H)-dicarboxylateBenzyl i ^-dihydro-i'H-spiroIindole-S^'-piperidineJ-i'-carboxylate [described in J. Xie et al., Tetrahedron, 2004, 60, 4875-4878] (251 mg, 0.78 mmol), methyl chloroformate (81 mg, 0.86 mmol) and triethylamine (0.15 ml, 0.97 mmol) were stirred in dichloromethane (5 ml) at room <n="184"/>temperature for 18 hours. The organic phase was washed with saturated aqueous sodium hydrogen carbonate (5 ml), dried (MgSO4), and loaded onto a silica gel column. Gradient elution with cyclohexane:Et2O (90:10 - 50:50) yielded the title compound as a colourless gum (85 mg, 0.22 mmol, 29%).MS m/z (APCI) 381 [MH]+

Reference： [1]Patent: WO2007/57775,2007,A1 .Location in patent: Page/Page column 182-183

30
[ 108-23-6 ]
[ 167484-18-6 ]
[ 937255-11-3 ]

Yield	Reaction Conditions	Operation in experiment
20%	With triethylamine; In dichloromethane; at 20℃; for 18h;	Preparation 126 1 '-Benzyl 1-isopropyl 1 'H-spirorindole-3,4'-piperidinel-1.1 '(2H)-dicarboxylate <n="185"/>Benzyl i^-dihydro-i'H-spiropndole-S^'-piperidineJ-i'-carboxylate [described in J. Xie et al., Tetrahedron, 2004, 60, 4875-4878] (251 mg, 0.78 mmol), isopropyl chloroformate (95 mg, 0.86 mmol) and triethylamine (0.15 ml, 0.97 mmol) were stirred in dichloromethane (5 ml) at room temperature for 18 hours. The organic phase was washed with saturated aqueous sodium hydrogen carbonate (5 ml), dried (MgSO4), and loaded onto a silica gel column. Gradient elution with cyclohexane/Et2O (90:10 - 50:50) yielded the title compound as a colourless gum (65 mg, 0.16 mmol, 20%). MS m/z (APCI) 409 [MH]+.

Reference： [1]Patent: WO2007/57775,2007,A1 .Location in patent: Page/Page column 183-184

31
[ 167484-18-6 ]
[ 171-75-5 ]

Yield	Reaction Conditions	Operation in experiment
78%	With palladium on activated charcoal; ammonium formate; In methanol; for 2h;Reflux;	Benzyl spiro[indoline-3,4?-piperidine] -1 ?-carboxylate (Compound of step 1 of Example 116, 0.7 g, 2.171 mmol) and ammonium formate (0.685 g, 10.86 mmol) were added to a suspension of Pd/C (0.231 g, 2.171 mmol) in MeOH (20 mL) at RT. The reaction mixture was refluxed for 2 h. After completion of reaction, the reaction mixture was filtered over celite bed. The filtrate was concentrated and the residue was purified by flash column chromatography (0-3 % MeOH chloroform with 0.5% aqueous ammonia as eluent, silica gel column) to obtain the title compound (0.32 g). Yield: 78%; H NMR (CDC13, 300 MHz):1.71-1.88 (m, 4H), 1.76 (t, J = 12.0 Hz, 2H), 3.09 (d, 12.0 Hz, 2H), 3.50 (s, 2H), 6.66 (d, J =7.2 Hz, 1H), 6.77 (t, J= 7.5 Hz, 1H), 7.05 (a, J= 7.5 Hz, 1H), 7.11 (a, J= 7.2 Hz, 1H); MS(mlz): [M+H]+ 189.1.
68%	With hydrogen;palladium 10% on activated carbon; In methanol; at 20℃;	A solution of <strong>[167484-18-6]phenylmethyl 1,2-dihydro-1'H-spiro[indole-3,4'-piperidine]-1'-carboxylate</strong> (12.72 g, 39.4 mmol) in 200 mL of MeOH in a 500-mL flask was purged with N2 for 15 min, after which time 10% Pd/C (5 g, approx 50% water) was added. The reaction flask was then purged with H2 and fitted with a balloon charged with H2. The reaction was allowed to stir at room temperature overnight. The mixture was then filtered through celite and the filtrate was concentrated. The celite/Pd/C mixture was stirred in 500 mL of MeOH for 30 min to extract remaining product that may have precipitated out of the reaction. The mixture was filtered through additional celite and the filtrate combined with the previous filtrate and concentrated. 5.05 g (26.7 mmol, 68% yield) of the desired product 1,2-dihydrospiro[indole-3,4'-piperidine] was obtained. MS (ES) m/e 189 [M+H]+.

Reference： [1]Patent: WO2015/28960,2015,A1 .Location in patent: Page/Page column 152; 153
[2]Patent: US2008/318990,2008,A1 .Location in patent: Page/Page column 22

Related Products

Historical Records

Related Functional Groups of
[ 167484-18-6 ]

Aryls

[ 167483-90-1 ]

Benzyl 1'-methylspiro[indoline-3,4'-piperidine]-1-carboxylate

Similarity: 0.96

[ 159635-46-8 ]

Benzyl spiro[indoline-3,4'-piperidine]-1-carboxylate hydrochloride

Similarity: 0.95

[ 1041704-16-8 ]

Benzyl 5-chlorospiro[indoline-3,4'-piperidine]-1'-carboxylate

Similarity: 0.93

[ 1160248-39-4 ]

Benzyl 3-(1-(tert-butoxycarbonyl)piperidin-4-yl)indoline-1-carboxylate

Similarity: 0.92

[ 1160248-34-9 ]

Benzyl 3-(1-(tert-butoxycarbonyl)piperidin-3-yl)indoline-1-carboxylate

Similarity: 0.92

Amides

[ 167483-90-1 ]

Benzyl 1'-methylspiro[indoline-3,4'-piperidine]-1-carboxylate

Similarity: 0.96

[ 159635-46-8 ]

Benzyl spiro[indoline-3,4'-piperidine]-1-carboxylate hydrochloride

Similarity: 0.95

[ 1041704-16-8 ]

Benzyl 5-chlorospiro[indoline-3,4'-piperidine]-1'-carboxylate

Similarity: 0.93

[ 1160248-25-8 ]

tert-Butyl 3-(indolin-3-yl)piperidine-1-carboxylate

Similarity: 0.93

[ 1129411-47-7 ]

tert-Butyl 5-methylspiro[indoline-3,4'-piperidine]-1'-carboxylate

Similarity: 0.93

Related Parent Nucleus of
[ 167484-18-6 ]

Indolines

[ 167483-90-1 ]

Benzyl 1'-methylspiro[indoline-3,4'-piperidine]-1-carboxylate

Similarity: 0.96

[ 159635-46-8 ]

Benzyl spiro[indoline-3,4'-piperidine]-1-carboxylate hydrochloride

Similarity: 0.95

[ 1041704-16-8 ]

Benzyl 5-chlorospiro[indoline-3,4'-piperidine]-1'-carboxylate

Similarity: 0.93

[ 1160248-25-8 ]

tert-Butyl 3-(indolin-3-yl)piperidine-1-carboxylate

Similarity: 0.93

[ 1129411-47-7 ]

tert-Butyl 5-methylspiro[indoline-3,4'-piperidine]-1'-carboxylate

Similarity: 0.93

Piperidines

[ 167483-90-1 ]

Benzyl 1'-methylspiro[indoline-3,4'-piperidine]-1-carboxylate

Similarity: 0.96

[ 159635-46-8 ]

Benzyl spiro[indoline-3,4'-piperidine]-1-carboxylate hydrochloride

Similarity: 0.95

[ 1041704-16-8 ]

Benzyl 5-chlorospiro[indoline-3,4'-piperidine]-1'-carboxylate

Similarity: 0.93

[ 1160248-25-8 ]

tert-Butyl 3-(indolin-3-yl)piperidine-1-carboxylate

Similarity: 0.93

[ 1129411-47-7 ]

tert-Butyl 5-methylspiro[indoline-3,4'-piperidine]-1'-carboxylate

Similarity: 0.93

Spiroes

[ 167483-90-1 ]

Benzyl 1'-methylspiro[indoline-3,4'-piperidine]-1-carboxylate

Similarity: 0.96

[ 159635-46-8 ]

Benzyl spiro[indoline-3,4'-piperidine]-1-carboxylate hydrochloride

Similarity: 0.95

[ 1041704-16-8 ]

Benzyl 5-chlorospiro[indoline-3,4'-piperidine]-1'-carboxylate

Similarity: 0.93

[ 1129411-47-7 ]

tert-Butyl 5-methylspiro[indoline-3,4'-piperidine]-1'-carboxylate

Similarity: 0.93

[ 676607-30-0 ]

1'-Benzyl 1-tert-butyl spiro[indoline-3,4'-piperidine]-1,1'-dicarboxylate

Similarity: 0.92

Ghs Precautionary Statements

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Purity	Size	Price	VIP Price	USA Stock *0-1 Day	Global Stock *5-7 Days	Quantity
{[ item.p_purity ]}	{[ item.pr_size ]}	{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]}	{[ getRatePrice(item.pr_usd, 1,1) ]}	{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]}	{[ item.pr_usastock ]}	Inquiry -	{[ item.pr_chinastock ]}	Inquiry -

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere

[ CAS No. 167484-18-6 ]

Quality Control of [ 167484-18-6 ]

Related Doc. of [ 167484-18-6 ]

Product Details of [ 167484-18-6 ]

Calculated chemistry of of [ 167484-18-6 ]

Physicochemical Properties

Pharmacokinetics

Lipophilicity

Druglikeness

Water Solubility

Medicinal Chemistry

Safety of [ 167484-18-6 ]

Application In Synthesis of [ 167484-18-6 ]

[ 167484-18-6 ] Synthesis Path-Downstream 1~31

Related Functional Groups of [ 167484-18-6 ]

Aryls

Amides

Related Parent Nucleus of [ 167484-18-6 ]

Indolines

Piperidines

Spiroes

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Related Functional Groups of
[ 167484-18-6 ]

Related Parent Nucleus of
[ 167484-18-6 ]